BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹2.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -0.06 | |
| Mar2024 | ₹18 Cr | 67.43 | |
| Mar2023 | ₹10 Cr | 69.85 | |
| Mar2022 | ₹6.17 Cr | 208.45 | |
| Mar2021 | ₹2.00 Cr | - | |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹292.7 Cr | 11% | -7.4% | 62.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 11% |
-7.4% |
62.5% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses